Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesStem cells and solid cancers
Virchows Archiv, 06/10/09
McDonald SAC et al. - In a review of stem cells and solid cancers, this article attempts to put these latest advances in stem cell biology and their potential for cancer therapy into perspective.
Methods- There have been significant advances in knowledge of stem cells found in tissues that can develop solid tumours.
- Novel stem cell markers have been identified for the first time identifying multipotential cells: a required characteristic of a stem cell.
- The scarcity of cancer stem cells has been questioned.
- Current dogma states that they are rare, but novel research has suggested that this may not be the case.
- Thsi article reviews the latest literature on stem cells, particularly cancer stem cells within solid tumours.
- It discusses current thinking on how stem cells develop into cancer stem cells and how they protect themselves from doing so and whether they express unique markers that can be used to detect stem cells.
Related Articles
New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09
Relevance Score: 69%
Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer
Journal of Clinical Oncology, 10/16/09
Relevance Score: 67%
An evidence-based consensus statement on the role and application of endosonography in clinical practice
Endoscopy, 10/30/09
Relevance Score: 66%
Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data
Cancer Chemotherapy and Pharmacology, 10/05/09
Relevance Score: 66%
BU-32: a novel proteasome inhibitor for breast cancer
Breast Cancer Research, 10/15/09
Relevance Score: 65%
Today in BMT/SCT...keeping you current
Receive free subspecialty "5-minute updates" via email
Disease status at autologous stem cell transplantation and the cell of origin phenotype are important predictors of outcome in patients with neurologic (central nervous system) relapse of diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
Leukemia and Lymphoma, 12/17/09
Does location matter? Rural vs urban outcomes after blood and marrow transplantation in a population-based Canadian cohort
Bone Marrow Transplantation, 12/16/09
Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome
Bone Marrow Transplantation, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor